Heterogeneity of macrophages in PD-1/PD-L1 inhibitor therapy: a single-cell perspective
Therapeutic blockade of the PD-1/PD-L1 signaling pathway is the focus of tumor immunotherapy. However, drug resistance and irAEs induced by PD-1/PD-L1 inhibitors have emerged as major limitations affecting survival outcomes in patients with cancer. Macrophages …
Read PDF